MKI67 and neoplasm: To further characterize the tumor response after combined i.t. 5FU with either 15 Gy EBRT or i.t. 5 MBq 18F-FLT in HCT116 xenograft tumors, the number of proliferating tumor cells was assessed by immunohistochemistry staining for Ki67 (Fig. 8).